These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23625134)

  • 61. Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies.
    Tokunaga N; Inoue C; Sakata T; Kagawa K; Abe M; Takamatsu N; Nakao T; Doi T
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):474-6. PubMed ID: 26523912
    [No Abstract]   [Full Text] [Related]  

  • 62. Severe acquired von Willebrand syndrome secondary to systemic lupus erythematosus.
    Stufano F; Baronciani L; Biguzzi E; Cozzi G; Colpani P; Chisini M; Peyvandi F
    Haemophilia; 2019 Jan; 25(1):e30-e32. PubMed ID: 30408840
    [No Abstract]   [Full Text] [Related]  

  • 63. Coincident systemic lupus erythematosus and psoriasis vulgaris: a case report.
    Wang Y; Da G; Yu Y; Han J; Li H
    G Ital Dermatol Venereol; 2015 Dec; 150(6):749-51. PubMed ID: 25058036
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Von Willebrand factor activity in patients with systemic lupus erythematosus].
    Shevchuk SV
    Lik Sprava; 2006; (5-6):39-43. PubMed ID: 17380869
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Factor VIII/von Willebrand factor concentrate for treatment of life threatening epistaxis in Glanzmann's thrombasthenia.
    Zinke RA; Ornstein DL; Holmes CE
    Haemophilia; 2010 Jul; 16(4):701-4. PubMed ID: 20331758
    [No Abstract]   [Full Text] [Related]  

  • 66. Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance.
    Yujiri T; Nakamura Y; Oota I; Nakano K; Tanizawa Y
    Ann Hematol; 2014 Aug; 93(8):1427-8. PubMed ID: 24337448
    [No Abstract]   [Full Text] [Related]  

  • 67. Elderly female with a personal and family history of a bleeding disorder.
    Desai DS; Lyon E; Rodgers GM; Jama MA; Wallentine SL; Smock KJ
    Clin Chem; 2015 Jul; 61(7):909-12. PubMed ID: 26116638
    [No Abstract]   [Full Text] [Related]  

  • 68. Inhibition of Willebrand factor in von Willebrand disease.
    Maragall S; Castillo R; Ordinas A; Liendo F; Rodríguez M
    Thromb Res; 1979; 14(2-3):495-500. PubMed ID: 312541
    [No Abstract]   [Full Text] [Related]  

  • 69. Discrepancy in von Willebrand factor activity determined by ristocetin cofactor and immunotubidometric assays.
    Reilly-Stitt C; Coppell J; Mumford AD
    Haemophilia; 2014 Jul; 20(4):e341-4. PubMed ID: 24758483
    [No Abstract]   [Full Text] [Related]  

  • 70. Acquired Von Willebrand's Syndrome in Systemic Lupus Erythematosus.
    Taveras Alam S; Alexis K; Sridharan A; Strakhan M; Elrafei T; Gralla RJ; Reed LJ
    Case Rep Hematol; 2014; 2014():208597. PubMed ID: 25544909
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease.
    Greaves M; Malia RG; Milford Ward A; Moult J; Holt CM; Lindsey N; Hughes P; Goodfield M; Rowell NR
    Br J Rheumatol; 1988 Aug; 27(4):281-5. PubMed ID: 3136816
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acquired von Willebrand's syndrome in systemic lupus erythematosus.
    Simone JV; Cornet JA; Abildgaard CF
    Blood; 1968 Jun; 31(6):806-12. PubMed ID: 4172730
    [No Abstract]   [Full Text] [Related]  

  • 73. Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.
    Baird JS; Johnson JL; Elliott-Mills D; Opas LM
    Lupus; 1997; 6(3):275-8. PubMed ID: 9104736
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Disorders of hemostatic function in patients with systemic lupus erythematosus.
    Lee SL; Miotti AB
    Semin Arthritis Rheum; 1975 Feb; 4(3):241-52. PubMed ID: 1091975
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systemic Lupus Erythematosus from Lupus Enteritis.
    Kawai J; Kakimoto K; Miyazaki H; Hirata Y; Kawakami K; Higuchi K
    J Gastrointestin Liver Dis; 2019 Jun; 28():147. PubMed ID: 31204411
    [No Abstract]   [Full Text] [Related]  

  • 76. Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus.
    Lafferty TE; Smith JB; Schuster SJ; DeHoratius RJ
    Arthritis Rheum; 1997 Apr; 40(4):775-8. PubMed ID: 9125263
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Angioedema as the presenting feature of systemic lupus erythematosus.
    Kumar N; Surendran D; Bammigatti C
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29593002
    [TBL] [Abstract][Full Text] [Related]  

  • 78. von Willebrand factor abnormalities in two patients with uraemia.
    Rodeghiero F; Castaman G; Lombardi R; Mannucci PM
    Lancet; 1988 Oct; 2(8618):1016-7. PubMed ID: 2902444
    [No Abstract]   [Full Text] [Related]  

  • 79. Von Willebrand disease as an endothelial-cell abnormality.
    Caen JP; Sultan Y
    Lancet; 1975 Dec; 2(7945):1129. PubMed ID: 53607
    [No Abstract]   [Full Text] [Related]  

  • 80. Systemic lupus erythematosus and spontaneously arising anticoagulants.
    Jacobs P; Bracher M; Meyers OL
    S Afr Med J; 1975 Oct; 49(45):1881-2. PubMed ID: 1188558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.